- Designed with customers, for customers – the Allia IGS 7 has achieved international recognition as a recipient of the Red Dot Design Award for Product Design
Chicago, United States – June 13, 2022 – As the demand for minimally invasive surgery continues to grow, GE Healthcare is committed to helping clinicians use image guidance technologies to their full potential by removing barriers to deliver quality patient care for better clinical and operational results.
New Allia platform represents the culmination of a multi-year collaboration with interventionists and surgeons with the goal of improving the user experience, improving workflow efficiency and increasing the adoption of patient guidance. image in daily practice – all important factors in today’s constrained healthcare environment.
Nearly 50% of procedures are performed at workstations where clinicians have limited access to the user interface, functions and display. The Allia platform was designed to meet these challenges – with users feeling the difference as soon as they step into the interventional or hybrid operating room, where they can access all of their essential functions from a personalized workplace with to intuitive and compact user interfaces. Allia IGS 7 brings flexibility with its gantry not mounted on the floor or the ceiling, allowing total mobility in the workplace. Additionally, Allia IGS 7 enables collision-free procedures with its wide bore C-arm design.
Building on the Edison platform, the Allia platform also harnesses the power of AI with AutoRight -the industry’s first AI-based interventional image chain – and Liver ASSIST virtual parenchyma – a 3D visualization software solution designed to provide virtual AI-based parenchymography to help clinicians dynamically simulate injections and perform liver embolization procedures with confidence.
Designed with customers, for customers, the innovative features and design of the Allia IGS 7 reflect insights gained from over 70 interactive sessions. As a result, users agree that Allia IGS 7 represents a significant advancement in the image-guided therapy suite space to support evolving practices in Interventional Radiology, Cardiology and Vascular Surgery, while providing excellent user experience.
In addition to positive feedback from clinicians since its introduction, the Allia IGS 7 has also achieved international recognition as a recent recipient of the Red Dot Design Award: Product Design 2022. The origins of the Red Dot Design Award date back to 1955 and its award, the Red Dot, has established itself internationally as one of the most sought-after marks of quality for good design.
“By collaborating with clinicians to redesign the image-guided therapy suite with a focus on ergonomics, ease of use, and workflow efficiency, our technology provides adaptability to the needs of a diverse set of clinical specialties allowing physicians to keep their focus where it belongs, on the patient.Excellent design is not only recognized, it is used.Receiving the Red Dot Product Design Award for the Allia IGS 7 is a wonderful recognition and further reinforces that prioritizing the voice of our customers is key to unleashing the full potential of our innovation,” – Arnaud Marie, CEO of Global Interventional.
GE Healthcare will be exhibiting the Allia IGS 7 and more at the Society of Interventional Radiology’s annual conference June 11-16. Visit GE Healthcare at booth #325 to learn more.
About the Red Dot Design Award: The “Red Dot” distinction has established itself internationally as one of the most sought-after seals of quality for good design. More information is available here.
 47%, according to a GE-sponsored blind survey of 30 interventional cardiologists and interventional radiologists in the US and Europe.
 Allia IGS 7 is FDA 510(k) cleared and CE marked. Not available for sale in all regions.
 AutoRight refers to the intelligent image chain capabilities of GEHC interventional radiology systems, from image acquisition to image processing and display.
 Liver ASSIST Virtual Parenchyma is FDA 510(k) cleared and CE marked. Not available for sale in all countries.
 Liver ASSIST Virtual Parenchyma solution includes Hepatic VCAR and FlightPlan for Liver with Parenchyma Analysis and requires AW workstation with Volume Viewer, Volume Viewer Innova, Vision 2, VesselIQ Xpress, Autobone Xpress. These apps are sold separately. The FlightPlan for Liver with Parenchyma Analysis option may not be available for sale in all countries.
 GE Healthcare archived data
 Result obtained during the evaluation of Allia IGS 7 by 19 clinicians from Europe and the United States, using a simulated interventional laboratory environment. The statement described here is based on the opinions of these healthcare professionals, who are paid consultants to GEHC and have been compensated for their participation.
About GE Healthcare:
GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a global leader in medical technology, pharmaceutical diagnostics and digital solutions innovation, GE Healthcare empowers clinicians to make faster, more informed decisions through smart devices, data analytics, apps and services, supported by its Edison intelligence platform. With more than 100 years of experience in the healthcare industry and approximately 48,000 employees worldwide, the company operates at the center of an ecosystem driving precision health, digitizing healthcare, helping to drive the productivity and improve outcomes for patients, providers, health systems and researchers around the world.
follow us on Facebook, LinkedIn, Twitter, instagram and Knowledge for the latest news, or visit our website www.gehealthcare.comfor more information.
Emily Dalton Niles | [email protected]